Michael Kremer Describes the Economics of Vaccine Development and Distribution
Vaccines that protect against SARS-CoV-2 are a critical element in the global response to the COVID-19 pandemic. In a recent presentation to the NBER Corporate Associates Symposium, Research Associate Michael Kremer of the University of Chicago described the work that he and his collaborators have done on the economics of vaccine development and distribution. The findings of this research, which are summarized in the video above, offer insights on the design of incentives for vaccine innovation, ways to obtain the maximum public health benefit from the distribution of fixed numbers of vaccine doses, and public policies that can enhance readiness for future pandemics. An archive of NBER videos on pandemic-related research may be found here.